Market revenue in 2022 | USD 654.4 million |
Market revenue in 2030 | USD 1,482.4 million |
Growth rate | 10.8% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyethylene (PE) |
Historical data covered | 2019 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 20.94% in 2024. Horizon Databook has segmented the Latin America biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
In Central & South America, healthcare spending is expected to rise gradually in the coming years. Several initiatives are being undertaken by the governments in the region to improve public healthcare systems amid budget constraints.
Several steps have been taken to attract private investments in the biopharma plastics of healthcare sector to improve the existing healthcare infrastructure in key countries such as Brazil and Argentina. This is expected to drive the biopharma plastics market over the forecast period.
Political instability, declining consumer confidence due to COVID-19 impact, and monetary tightening have had adverse effects on the Brazilian economy, affecting the demand for biopharma plastics in the country. As a result, Central & South America biopharma plastics market is expected to witness moderate growth over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biopharma plastics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account